PT1733725E - Formulações farmacêuticas compreendendo pelo menos um composto inibidor da protease de hiv - Google Patents
Formulações farmacêuticas compreendendo pelo menos um composto inibidor da protease de hiv Download PDFInfo
- Publication number
- PT1733725E PT1733725E PT06114684T PT06114684T PT1733725E PT 1733725 E PT1733725 E PT 1733725E PT 06114684 T PT06114684 T PT 06114684T PT 06114684 T PT06114684 T PT 06114684T PT 1733725 E PT1733725 E PT 1733725E
- Authority
- PT
- Portugal
- Prior art keywords
- farmaceutical
- formulations
- hiv protease
- inhibiting compound
- protease inhibiting
- Prior art date
Links
- 108091005804 Peptidases Proteins 0.000 title 1
- 239000004365 Protease Substances 0.000 title 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 238000009472 formulation Methods 0.000 title 1
- 230000002401 inhibitory effect Effects 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4433—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
- A61K31/4725—Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US32582699A | 1999-06-04 | 1999-06-04 |
Publications (1)
Publication Number | Publication Date |
---|---|
PT1733725E true PT1733725E (pt) | 2009-06-30 |
Family
ID=23269615
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT00937743T PT1183026E (pt) | 1999-06-04 | 2000-05-25 | Formulações farmacêuticas melhoradas incluindo ritonavir |
PT06114684T PT1733725E (pt) | 1999-06-04 | 2000-05-25 | Formulações farmacêuticas compreendendo pelo menos um composto inibidor da protease de hiv |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT00937743T PT1183026E (pt) | 1999-06-04 | 2000-05-25 | Formulações farmacêuticas melhoradas incluindo ritonavir |
Country Status (33)
Country | Link |
---|---|
EP (2) | EP1733725B2 (pt) |
JP (1) | JP4753511B2 (pt) |
KR (1) | KR100815412B1 (pt) |
CN (2) | CN101361723B (pt) |
AR (2) | AR032586A1 (pt) |
AT (2) | ATE429224T1 (pt) |
AU (1) | AU778198B2 (pt) |
BG (1) | BG65445B1 (pt) |
BR (1) | BR0007294A (pt) |
CA (1) | CA2371109C (pt) |
CL (1) | CL2008003491A1 (pt) |
CO (1) | CO5160323A1 (pt) |
CY (2) | CY1105237T1 (pt) |
CZ (1) | CZ301308B6 (pt) |
DE (2) | DE60042092D1 (pt) |
DK (2) | DK1733725T4 (pt) |
ES (2) | ES2265946T3 (pt) |
HK (1) | HK1045804A1 (pt) |
HU (1) | HU229501B1 (pt) |
IL (3) | IL146025A0 (pt) |
MX (1) | MXPA01012478A (pt) |
MY (1) | MY127908A (pt) |
NO (1) | NO328968B1 (pt) |
NZ (1) | NZ515016A (pt) |
PL (1) | PL197671B1 (pt) |
PT (2) | PT1183026E (pt) |
SA (1) | SA00210237B1 (pt) |
SI (2) | SI1183026T1 (pt) |
SK (2) | SK287185B6 (pt) |
TR (1) | TR200103488T2 (pt) |
TW (1) | TWI244390B (pt) |
WO (1) | WO2000074677A2 (pt) |
ZA (1) | ZA200108641B (pt) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MY121765A (en) * | 1998-07-20 | 2006-02-28 | Abbott Lab | Polymorph of ritonavir |
TR200103488T2 (tr) * | 1999-06-04 | 2002-04-22 | Abbott Laboratories | Geliştirilmiş farmasötik formülasyonlar. |
US7141593B1 (en) | 1999-06-04 | 2006-11-28 | Abbott Laboratories | Pharmaceutical formulations |
JP5767429B2 (ja) | 1999-11-12 | 2015-08-19 | アッヴィ・インコーポレイテッド | 固体分散剤中の結晶化阻害剤 |
CA2395987C (en) * | 2000-01-19 | 2009-12-22 | Abbott Laboratories | Improved pharmaceutical formulations |
EP1395249A1 (en) * | 2001-05-25 | 2004-03-10 | Abbott Laboratories | Soft elastic capsules comprising ritonavir and/or lopinavir |
US8025899B2 (en) | 2003-08-28 | 2011-09-27 | Abbott Laboratories | Solid pharmaceutical dosage form |
US20050048112A1 (en) | 2003-08-28 | 2005-03-03 | Jorg Breitenbach | Solid pharmaceutical dosage form |
EP2308490A1 (en) * | 2005-12-30 | 2011-04-13 | Gilead Sciences, Inc. | Methods for improving the pharmacokinetics of hiv integrase inhibitors |
AU2015258296B2 (en) * | 2006-07-07 | 2017-08-17 | Gilead Sciences, Inc. | Modulators of pharmacokinetic properties of therapeutics |
AU2013204805C1 (en) * | 2006-07-07 | 2017-03-09 | Gilead Sciences, Inc. | Modulators of pharmacokinetic properties of therapeutics |
EP2049506B2 (en) * | 2006-07-07 | 2024-05-08 | Gilead Sciences, Inc. | Modulators of pharmacokinetic properties of therapeutics |
AU2015234299B2 (en) * | 2006-07-07 | 2017-03-09 | Gilead Sciences, Inc. | Modulators of pharmacokinetic properties of therapeutics |
NO345893B1 (no) * | 2006-07-07 | 2021-09-27 | Gilead Sciences Inc | Modulatorer av farmakokinetikkegenskaper til terapeutika |
WO2008067164A2 (en) | 2006-11-15 | 2008-06-05 | Abbott Laboratories | Solid pharmaceutical dosage formulations |
LT2487166T (lt) * | 2007-02-23 | 2016-11-10 | Gilead Sciences, Inc. | Terapinių agentų farmakokinetinių savybių moduliatoriai |
AU2013204815B2 (en) * | 2007-02-23 | 2015-05-07 | Gilead Sciences, Inc. | Modulators of pharmacokinetic properties of therapeutics |
DK2487161T4 (da) | 2007-02-23 | 2024-06-24 | Gilead Sciences Inc | Modulatorer af farmakokinetiske egenskaber af terapeutika |
AU2015204378B2 (en) * | 2007-02-23 | 2017-03-09 | Gilead Sciences, Inc. | Modulators of pharmacokinetic properties of therapeutics |
CA2692331A1 (en) | 2007-07-06 | 2009-01-15 | Gilead Sciences, Inc. | Modulators of pharmacokinetic properties of therapeutics |
CA2710679A1 (en) | 2008-01-04 | 2009-07-16 | Gilead Sciences, Inc. | Inhibitors of cytochrome p450 |
UA108738C2 (uk) * | 2009-04-03 | 2015-06-10 | Спосіб одержання інгібітора цитохром р450 монооксигенази та залучені проміжні сполуки |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5552558A (en) * | 1989-05-23 | 1996-09-03 | Abbott Laboratories | Retroviral protease inhibiting compounds |
GB8927913D0 (en) * | 1989-12-11 | 1990-02-14 | Hoffmann La Roche | Amino acid derivatives |
US5413999A (en) * | 1991-11-08 | 1995-05-09 | Merck & Co., Inc. | HIV protease inhibitors useful for the treatment of AIDS |
IL110752A (en) * | 1993-09-13 | 2000-07-26 | Abbott Lab | Liquid semi-solid or solid pharmaceutical composition for an HIV protease inhibitor |
US5559158A (en) * | 1993-10-01 | 1996-09-24 | Abbott Laboratories | Pharmaceutical composition |
IL111991A (en) † | 1994-01-28 | 2000-07-26 | Abbott Lab | Liquid pharmaceutical composition of HIV protease inhibitors in organic solvent |
CA2185803C (en) * | 1994-03-18 | 2006-07-11 | Edward M. Rudnic | Emulsified drug delivery systems |
DE4431489A1 (de) * | 1994-09-03 | 1996-03-07 | Heidelberger Baustofftech Gmbh | Schnellhärtende aminosilanvernetzende Silikonmassen |
US5567823A (en) * | 1995-06-06 | 1996-10-22 | Abbott Laboratories | Process for the preparation of an HIV protease inhibiting compound |
US6037157A (en) * | 1995-06-29 | 2000-03-14 | Abbott Laboratories | Method for improving pharmacokinetics |
EP1295874A3 (en) * | 1995-12-13 | 2003-04-02 | Abbott Laboratories | Retroviral protease inhibiting compounds |
US5914332A (en) * | 1995-12-13 | 1999-06-22 | Abbott Laboratories | Retroviral protease inhibiting compounds |
ZA9710071B (en) * | 1996-11-21 | 1998-05-25 | Abbott Lab | Pharmaceutical composition. |
MY121765A (en) * | 1998-07-20 | 2006-02-28 | Abbott Lab | Polymorph of ritonavir |
TR200103488T2 (tr) * | 1999-06-04 | 2002-04-22 | Abbott Laboratories | Geliştirilmiş farmasötik formülasyonlar. |
-
2000
- 2000-05-25 TR TR2001/03488T patent/TR200103488T2/xx unknown
- 2000-05-25 SK SK5083-2007A patent/SK287185B6/sk not_active IP Right Cessation
- 2000-05-25 IL IL14602500A patent/IL146025A0/xx unknown
- 2000-05-25 HU HU0201591A patent/HU229501B1/hu not_active IP Right Cessation
- 2000-05-25 PT PT00937743T patent/PT1183026E/pt unknown
- 2000-05-25 KR KR1020017015577A patent/KR100815412B1/ko active IP Right Grant
- 2000-05-25 ES ES00937743T patent/ES2265946T3/es not_active Expired - Lifetime
- 2000-05-25 DK DK06114684.1T patent/DK1733725T4/da active
- 2000-05-25 SI SI200030880T patent/SI1183026T1/sl unknown
- 2000-05-25 WO PCT/US2000/014342 patent/WO2000074677A2/en active Application Filing
- 2000-05-25 MX MXPA01012478A patent/MXPA01012478A/es active IP Right Grant
- 2000-05-25 JP JP2001501214A patent/JP4753511B2/ja not_active Expired - Lifetime
- 2000-05-25 CZ CZ20014293A patent/CZ301308B6/cs not_active IP Right Cessation
- 2000-05-25 CN CN2008101301744A patent/CN101361723B/zh not_active Expired - Lifetime
- 2000-05-25 DE DE60042092T patent/DE60042092D1/de not_active Expired - Lifetime
- 2000-05-25 PL PL351943A patent/PL197671B1/pl unknown
- 2000-05-25 SI SI200031028T patent/SI1733725T2/sl unknown
- 2000-05-25 AT AT06114684T patent/ATE429224T1/de active
- 2000-05-25 EP EP06114684A patent/EP1733725B2/en not_active Revoked
- 2000-05-25 DE DE60029219T patent/DE60029219T2/de not_active Expired - Lifetime
- 2000-05-25 AT AT00937743T patent/ATE332132T1/de active
- 2000-05-25 CA CA2371109A patent/CA2371109C/en not_active Expired - Lifetime
- 2000-05-25 AU AU52877/00A patent/AU778198B2/en not_active Revoked
- 2000-05-25 BR BR0007294-0A patent/BR0007294A/pt not_active Application Discontinuation
- 2000-05-25 NZ NZ515016A patent/NZ515016A/xx not_active IP Right Cessation
- 2000-05-25 EP EP00937743A patent/EP1183026B1/en not_active Revoked
- 2000-05-25 CN CNB008083207A patent/CN100418527C/zh not_active Expired - Lifetime
- 2000-05-25 SK SK1720-2001A patent/SK286305B6/sk not_active IP Right Cessation
- 2000-05-25 DK DK00937743T patent/DK1183026T3/da active
- 2000-05-25 ES ES06114684T patent/ES2324549T5/es not_active Expired - Lifetime
- 2000-05-25 PT PT06114684T patent/PT1733725E/pt unknown
- 2000-05-31 MY MYPI20002425A patent/MY127908A/en unknown
- 2000-05-31 CO CO00040645A patent/CO5160323A1/es unknown
- 2000-06-02 AR ARP000102748A patent/AR032586A1/es not_active Application Discontinuation
- 2000-06-03 TW TW089110863A patent/TWI244390B/zh active
- 2000-07-17 SA SA00210237A patent/SA00210237B1/ar unknown
-
2001
- 2001-10-18 IL IL146025A patent/IL146025A/en active IP Right Grant
- 2001-10-19 ZA ZA200108641A patent/ZA200108641B/en unknown
- 2001-11-20 NO NO20015670A patent/NO328968B1/no not_active Application Discontinuation
- 2001-12-19 BG BG106239A patent/BG65445B1/bg unknown
-
2002
- 2002-07-31 HK HK02105647A patent/HK1045804A1/xx not_active IP Right Cessation
-
2006
- 2006-09-21 CY CY20061101354T patent/CY1105237T1/el unknown
-
2007
- 2007-12-12 AR ARP070105573A patent/AR064309A2/es not_active Application Discontinuation
-
2008
- 2008-11-24 CL CL2008003491A patent/CL2008003491A1/es unknown
-
2009
- 2009-06-29 CY CY20091100675T patent/CY1109135T1/el unknown
-
2011
- 2011-11-29 IL IL216686A patent/IL216686A/en active IP Right Grant
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SI1733725T1 (sl) | Farmacevtske formulacije, vsebujoče vsaj eno spojino za inhibicijo HIV proteaze | |
HUP0202797A3 (en) | Compositions having improved stability | |
GB9917976D0 (en) | Herbicidal compositions | |
EP1334724A4 (en) | COMPOSITIONS FOR TOPICAL PREPARATIONS | |
MXPA02005067A (es) | Composicion inhibidora de la corrosion. | |
GB9921037D0 (en) | Compositions | |
IL135178A0 (en) | Pesticidal compositions | |
GB9924797D0 (en) | Compound | |
HUP0105279A3 (en) | Compositions having improved stability | |
GB9904049D0 (en) | Rapidly-soluble compositions | |
PL352088A1 (en) | Fungicidal compositions | |
PL352087A1 (en) | Fungicidal compositions | |
GB9921928D0 (en) | Compound | |
GB9929622D0 (en) | Compositions | |
EP1149892A4 (en) | SURFACE ACTIVE COMPOSITION | |
GB0031563D0 (en) | Compound | |
GB9914342D0 (en) | Compound | |
GB0031557D0 (en) | Compound | |
GB9903924D0 (en) | Cosmectic compositions | |
GB9904931D0 (en) | Compositions | |
GB9921929D0 (en) | Compound | |
GB9926833D0 (en) | Compositions | |
GB9924965D0 (en) | Compound | |
GB9910118D0 (en) | Formulations | |
GB9904057D0 (en) | Compositions |